Prediction of Recurrent Cervical Cancer in 2-Year Follow-Up After Treatment Based on Quantitative and Qualitative Magnetic Resonance Imaging Parameters: A Preliminary Study

被引:5
作者
Liu, Jie [1 ]
Li, Shujian [1 ]
Cao, Qinchen [2 ]
Zhang, Yong [1 ]
Nickel, Marcel Dominik [3 ]
Zhu, Jinxia [4 ]
Cheng, Jingliang [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept MRI, Zhengzhou, Henan, Peoples R China
[2] Zhengzhou Univ, Affiliated Hosp 1, Dept Radiotreatment, Zhengzhou, Henan, Peoples R China
[3] Siemens Healthcare GmbH, MR Applicat Predev, Erlangen, Germany
[4] Siemens Healthineers Ltd, MR Collaborat, Beijing, Peoples R China
关键词
APPARENT DIFFUSION-COEFFICIENT; CARCINOMA; STAGE; STRATIFICATION; INVOLVEMENT; DISEASE;
D O I
10.1245/s10434-023-13756-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose. This study investigated predictors of cervical cancer (CC) recurrence from native T1 mapping, conventional imaging, and clinicopathologic metrics.Patients and Methods. In total, 144 patients with histopathologically confirmed CC (90 with and 54 without surgical treatment) were enrolled in this prospective study. Native T1 relaxation time, conventional imaging, and clinicopathologic characteristics were acquired. The association of quantitative and qualitative parameters with post-treatment tumor recurrence was assessed using univariate and multivariate Cox proportional hazard regression analyses. Independent risk factors were combined into a model and individual prognostic index equation for predicting recurrence risk. The receiver operating characteristic (ROC) curve determined the optimal cutoff point.Results. In total, 12 of 90 (13.3%) surgically treated patients experienced tumor recurrence. Native T1 values (X1) [hazard ratio (HR) 1.008; 95% confidence interval (CI) 1.001-1.016], maximum tumor diameter (X2) (HR 1.065; 95% CI 1.020-1.113), and parametrial invasion (X3) (HR 3.930; 95% CI 1.013-15.251) were independent tumor recurrence risk factors. The individual prognostic index (PI) of the established recurrence risk model was PI = 0.008X1 + 0.063X2 + 1.369X3. The area under the ROC curve (AUC) of the Cox regression model was 0.923. A total of 20 of 54 (37.0%) non-surgical patients experienced tumor recurrence. Native T1 values (X1) (HR 1.012; 95% CI 1.007-1.016) and lymph node metastasis (X2) (HR 4.064; 95% CI 1.378-11.990) were independent tumor recurrence risk factors. The corresponding PI was calculated as follows: PI = 0.011X1 + 1.402X2; the Cox regression model AUC was 0.921.Conclusions. Native T1 values combined with conventional imaging and clinicopathologic variables could facilitate the pretreatment prediction of CC recurrence.
引用
收藏
页码:5577 / 5585
页数:9
相关论文
共 41 条
[1]   Native T1 Mapping as an In Vivo Biomarker for the Identification of Higher-Grade Renal Cell Carcinoma Correlation With Histopathological Findings [J].
Adams, Lisa C. ;
Ralla, Bernhard ;
Jurmeister, Philipp ;
Bressem, Keno K. ;
Fahlenkamp, Ute L. ;
Ilamm, Bernd ;
Busch, Jonas ;
Makowski, Marcus R. .
INVESTIGATIVE RADIOLOGY, 2019, 54 (02) :118-128
[2]   Lymphatic spread of cervical cancer: An anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy [J].
BenedettiPanici, P ;
Maneschi, F ;
Scambia, G ;
Greggi, S ;
Cutillo, G ;
DAndrea, G ;
Rabitti, C ;
Coronetta, F ;
Capelli, A ;
Mancuso, S .
GYNECOLOGIC ONCOLOGY, 1996, 62 (01) :19-24
[3]   The Prognostic Impact of Grading in FIGO IB and IIB Squamous Cell Cervical Carcinomas [J].
Brambs, Christine E. ;
Hoehn, Anne Katrin ;
Hentschel, Bettina ;
Fischer, Uta ;
Bilek, Karl ;
Horn, Lars-Christian .
GEBURTSHILFE UND FRAUENHEILKUNDE, 2019, 79 (02) :198-204
[4]   The association between serum squamous cell carcinoma antigen and recurrence and survival of patients with cervical squamous cell carcinoma: A systematic review and meta-analysis [J].
Charakorn, Chuenkamon ;
Thadanipon, Kunlawat ;
Chaijindaratana, Sawarat ;
Rattanasiri, Sasivimol ;
Numthavaj, Pawin ;
Thakkinstian, Ammarin .
GYNECOLOGIC ONCOLOGY, 2018, 150 (01) :190-200
[5]  
Csutak Csaba, 2016, Clujul Med, V89, P410, DOI 10.15386/cjmed-558
[6]   Surgical Treatment of Early-Stage Cervical Cancer: A Multi-Institution Experience in 2124 Cases in The Netherlands Over a 30-Year Period [J].
Derks, Marloes ;
van der Velden, Jacobus ;
de Kroon, Cornelis D. ;
Nijman, Hans W. ;
van Lonkhuijzen, Luc R. C. W. ;
van der Zee, Ate G. J. ;
Zwinderman, Aeilko H. ;
Kenter, Gemma G. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (04) :757-763
[7]   Diagnostic accuracy of MRI texture analysis for grading gliomas [J].
Ditmer, Austin ;
Zhang, Bin ;
Shujaat, Taimur ;
Pavlina, Andrew ;
Luibrand, Nicholas ;
Gaskill-Shipley, Mary ;
Vagal, Achala .
JOURNAL OF NEURO-ONCOLOGY, 2018, 140 (03) :583-589
[8]   Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 [J].
Ferlay, Jacques ;
Soerjomataram, Isabelle ;
Dikshit, Rajesh ;
Eser, Sultan ;
Mathers, Colin ;
Rebelo, Marise ;
Parkin, Donald Maxwell ;
Forman, David ;
Bray, Freddie .
INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (05) :E359-E386
[9]   Association of Apparent Diffusion Coefficient with Disease Recurrence in Patients with Locally Advanced Cervical Cancer Treated with Radical Chemotherapy and Radiation Therapy [J].
Gladwish, Adam ;
Milosevic, Michael ;
Fyles, Anthony ;
Xie, Jason ;
Halankar, Jaydeep ;
Metser, Ur ;
Jiang, Haiyan ;
Becker, Nathan ;
Levin, Wilfred ;
Manchul, Lee ;
Foltz, Warren ;
Han, Kathy .
RADIOLOGY, 2016, 279 (01) :158-166
[10]   The prognostic value of PET and PET/CT in cervical cancer [J].
Grigsby, Perry W. .
CANCER IMAGING, 2008, 8 (01) :146-155